PLOS Biology features works of exceptional significance, originality, and relevance in all areas of biological science, from molecules to ecosystems, including works at the interface of other disciplines, such as chemistry, medicine, and mathematics. We also welcome data-driven meta-research articles that evaluate and aim to improve the standards of research in the life sciences and beyond. Our audience is the international scientific community as well as educators, policy makers, patient advocacy groups, and interested members of the public around the world.
Data-driven research articles:
- Outstanding primary research articles in all aspects of biology.
- Provocative short reports based on a more limited number of experiments
- Outstanding methods and resource articles
- Outstanding meta-research articles that examine how research is (or should be) designed, carried out, communicated, and evaluated.
- A rich magazine section, featuring Essays, Perspectives, Unsolved Mysteries, Community Pages, Primers, and more. Read more about the magazine article types we publish.
PLOS Biology is highly selective in the manuscripts that it publishes; rejection rates are high. To be considered for publication in PLOS Biology, any given manuscript must be exceptional in the following ways:
Importance to researchers in its field
Interest to scientists outside the field
- Rigorous methodology and substantial evidence for its conclusions
Our aim is to provide all authors with an efficient, courteous, and constructive editorial process. To ensure the fairest and most objective decision-making, the editorial process is run as a partnership between the PLOS Biology professional editors and the Editorial Board, which is comprised of leaders in all fields of biology.
The ultimate responsibility for the PLOS Biology content and editorial decision-making lies with the team of professional editors.
PLOS Biology is supported by a number of freelance associate editors who support the PLOS Biology editors by providing input during the editorial process.
PLOS applies the Creative Commons Attribution (CC BY) license to works we publish. This license was developed to facilitate open access – namely, free immediate access to, and unrestricted reuse of, original works of all types.
Under this license, authors agree to make articles legally available for reuse, without permission or fees, for virtually any purpose. Anyone may copy, distribute, or reuse these articles, as long as the author and original source are properly cited. Read PLOS’ licenses and copyright policy.
At PLOS, we believe that research articles should primarily be judged on their individual merits, rather than on the basis of the journal in which they were published. In March 2009, we inaugurated a program to provide Article-Level Metrics (ALM) on every article across all journals. Article-Level Metrics (ALMs) capture the manifold ways in which research is disseminated and can help users determine the value of an article to them and to their scientific community. Read more about Article-Level Metrics.
Visit the Contact page for details about whom to contact with different queries.
PLOS Biology publication fees are US$2900 per manuscript and will be billed upon acceptance. Authors’ ability to pay publication fees will never be a consideration in the decision whether to publish. Read more about publication fees and publication fee support.
PLOS publishes a suite of influential journals from all areas of science and medicine that contain rigorously reported, peer reviewed Open Access research articles. The journals vary in their criteria for publication and, with the exception of PLOS ONE, also publish a variety of influential and educational non-research content. The journals are editorially independent. Read more about the PLOS suite of journals.